The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
The Extensior South Africa launch on 27 July, offering patients a lower-cost, authorised semaglutide treatment for type 2 diabetes. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Sun Pharma’s Generic Semaglutide is now available in South Africa. Explore this new treatment option for type 2 diabetes. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
